Fatty liver disease happens when excess fat builds up in liver cells, categorized into
Life-saving dual organ transplantation with 80% 5-year survival rates
Symptoms: Fatigue, abdominal discomfort, and jaundice (in advanced stages).
Blood Tests: ALT/AST ratios, lipid profiles, and HbA1c.
Exercise: 150+ minutes/week of moderate activity.
Holistic Support: Nutritionists, endocrinologists, and mental health counselors.
Rahul’s Transformation
“At 110 kg, I had advanced NASH. Dr. Ashish George’s team in Delhi helped me lose 25 kg and reverse fibrosis. My liver is healthy again!”
Priya’s Journey to Recovery
“Diagnosed with severe MASLD and advanced fibrosis at 35, I feared irreversible damage. Dr. Ashish George’s Delhi team crafted a plan with diet, exercise, and targeted meds. I lost 18 kg, and my FibroScan® score dropped from 12.4 kPa to 6.8 kPa – my liver is healing!”
Yes! Early-stage MASLD (steatosis) is fully reversible with lifestyle changes. Even NASH patients show significant improvement with 7-10% weight loss and targeted medications under medical supervision.
Excess body fat triggers insulin resistance, causing the liver to overproduce and store fat. Our Delhi clinic's integrated program combines:
• Medical weight management
• MASLD-specific nutrition plans
• Exercise physiology
to achieve both weight loss and liver health improvement.
Dr. Ashish George recommends biopsies only when:
• FibroScan® results are inconclusive
• Suspected advanced fibrosis (F3-F4)
• Evaluating for clinical trials
Our Delhi center uses transient elastography for 90% of cases, minimizing patient discomfort.
Our liver nutritionists recommend:
• Mediterranean-style eating pattern
• 25-30g fiber daily from whole grains
• Lean proteins (plant-based preferred)
• Healthy fats (nuts, olive oil, fatty fish)
• Strict avoidance of:
- Sugary beverages
- Processed snacks
- Trans fats
Dr. Ashish George's therapeutic approach:
Early NASH:
• Vitamin E (800IU/day)
• Pioglitazone (30mg/day)
Advanced fibrosis:
• GLP-1 agonists (semaglutide)
• FXR agonists when available
All treatments are combined with lifestyle modification programs at our Delhi center.
Yes. Patients with NASH cirrhosis have 2-12% annual risk of HCC. Our surveillance protocol includes:
• Quarterly ultrasound + AFP
• Biannual FibroScan®
• MRI for high-risk cases
Early detection at our India clinics improves 5-year survival to >70%.
Genetic factors contribute:
• PNPLA3 variant increases risk 3-fold
• TM6SF2 affects lipid metabolism
Our Delhi clinic offers:
• Genetic testing for high-risk families
• Personalized prevention plans
• Family screening programs
Lifestyle modifications remain key regardless of genetic risk.
Metabolic surgery benefits include:
• 60-80% excess weight loss
• NASH resolution in 85% of cases
• Fibrosis improvement in 40%
Dr. Ashish George collaborates with bariatric surgeons to:
• Select appropriate candidates (BMI >35 with NASH)
• Optimize pre-op liver health
• Provide post-surgical metabolic monitoring